Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Efficacy and safety of valganciclovir in prophylaxis of cytomegalovirus disease in renal transplant recipients

Efficacy and safety of valganciclovir in prophylaxis of cytomegalovirus disease in renal transplant recipients. Pharmacotherapy. 2003; 23(3):412-3.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.